Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.